Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2014

GlobalData
May 5, 2014
71 Pages - GLDATA18045
$2,500.00

Summary

GlobalData's clinical trial report, “Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2014" provides data on the Addison’s Disease (Primary or Chronic Adrenal Insufficiency) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Addison’s Disease (Primary or Chronic Adrenal Insufficiency). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Addison’s Disease (Primary or Chronic Adrenal Insufficiency). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Addison's Disease (Primary or Chronic Adrenal Insufficiency) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Addison's Disease (Primary or Chronic Adrenal Insufficiency) 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Shire Plc 29
Clinical Trial Overview of Shire Plc 29
DuoCort AB 30
Clinical Trial Overview of DuoCort AB 30
Clinical Trial Overview of Top Institutes / Government 31
Haukeland University Hospital 31
Clinical Trial Overview of Haukeland University Hospital 31
UMC Utrecht Holding BV 32
Clinical Trial Overview of UMC Utrecht Holding BV 32
University of Wurzburg 33
Clinical Trial Overview of University of Wurzburg 33
HaEmek Medical Center 34
Clinical Trial Overview of HaEmek Medical Center 34
Aarhus University 35
Clinical Trial Overview of Aarhus University 35
Newcastle University 36
Clinical Trial Overview of Newcastle University 36
University Hospital Tubingen 37
Clinical Trial Overview of University Hospital Tubingen 37
Nantes University Hospital 38
Clinical Trial Overview of Nantes University Hospital 38
Oregon Health and Science University 39
Clinical Trial Overview of Oregon Health and Science University 39
Rigshospitalet 40
Clinical Trial Overview of Rigshospitalet 40
Five Key Clinical Profiles 41
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

List of Tables
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 23
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014* 29
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by DuoCort AB, 2014* 30
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Haukeland University Hospital, 2014* 31
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014* 32
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wurzburg, 2014* 33
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014* 34
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 35
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Newcastle University, 2014* 36
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Tubingen, 2014* 37
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nantes University Hospital, 2014* 38
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 39
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 40

List of Figures
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 70

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax